QDEL QuidelOrtho Expected net earnings per share growth this year
QuidelOrtho (QDEL) is undergoing a post-merger management restructuring phase to identify synergies. Logistics and production efficiency are maintained through external outsourcing. Traditional laboratory tests serve as a cash cow, generating a stable cash flow. Annual EPS variability demonstrates profit resilience to inflation, with the value stabilizing at -68.40, which is critical for assessing margins.
Financial and market metric breakdowns for QuidelOrtho (QDEL)
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and liquidity details:
- business earnings and investment ratios data:
QDEL - Company Net Income|Expected Net Income QuidelOrtho|QDEL - Price to Earnings Ratio|Market Cap to Future Earnings Ratio QuidelOrtho Inc.|QDEL - PEG Multiple|Business Value to Operating Income Before Depreciation QuidelOrtho Inc.|QDEL - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months QuidelOrtho|QDEL - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year quidel.com|QDEL - Earnings growth in current year|Projected earnings per share growth rate for next year QuidelOrtho
Fundamental valuation:QDEL Quidel Corporation
This indicator captures the year-over-year dynamics of earnings per share, revealing capital management efficiency and the resilience of operating margins to market shocks. Investors analyze the annual EPS growth trajectory to assess the solvency of QuidelOrtho (QDEL), given that reliance on external component suppliers may impact final profitability during logistics disruptions.
Main competitors
A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform (ILMN) - Expected net earnings per share growth this year|Earnings per share growth in current year Exact Sciences (EXAS)|revvity.com (RVTY) - Net earnings per share change in current year|Bio-Rad - Net earnings per share growth this year|Earnings growth in current year Anbio Biotechnology Ltd NNNN|Sterigenics - Earnings growth in current year|Expected net earnings per share growth this year OPKO Health Corp. OPK|CDNA: Earnings growth in current year|Earnings per share growth this year MRVI|FLGT (Fulgent Genetics) - Earnings growth in current year|Earnings per share growth rate in current year Standard BioTools Inc LAB|Earnings per share growth in current year Cytek Bio (CTKB)|Earnings per share growth in current year OSUR (OraSure Corp)|Earnings per share growth in current year Exagen XGN|mdxhealth.com (MDXH) - Earnings per share growth rate in current year|LUCD - Earnings per share growth in current year|Earnings per share increase in current year PRE (Prenetics Global)|IMDX (imdxinc.com) - Net earnings per share growth this year|TRIB: Net earnings per one share growth for the current year|PRPH (ProPhase Labs, Inc.) - Earnings growth in current year|AIMD: Earnings per share increase in current year|Earnings per share growth in current year Co-Diagnostics (CODX)|HSCS - Earnings per share growth rate in current year|Earnings per share growth in current year Biomerica, Inc BMRA|Net earnings per share change in current year Cardio Diagnostics Holdings Inc.|Onconetix, Inc. - Earnings growth in current year|VRAX (viraxbiolabs.com) - Earnings per share growth this year|BJDX: Earnings growth in current year|Earnings per share growth rate in current year Aspira Women's Health, Inc. (AWH)|Earnings per share growth in current year Accelerate Diagnostics, Inc|Earnings per share growth in current year CNTG|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|Net earnings per share growth this year fresh2.co FRES|Earnings growth in current year GENE (Genetic Technologies Limited)|23andMe Holding Co (ME) - Earnings per share growth rate in current year|Psychemedics Corp - Earnings growth in current year
